In the first half of financial year 2019 Indian pharmaceutical companies saw an increase of 11.6 percent in the net profit margins. This was a relief after a dip of 9.7 percent in the first half of fiscal year 2018.
Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Operating margin in Indian pharma companies in 2017-2019
- Premium Statistic Net sales of Indian pharma companies in 2017-2019
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic China's share in drug and pharma imports in India 2019, by segment
- Premium Statistic Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- Premium Statistic Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Basic Statistic Medicine spending in emerging pharmaceutical markets 2026
- Premium Statistic Growth rate of R&D spending in pharmaceutical industry by major region 2007-2022
- Premium Statistic Pharmaceutical industry: EU trade partners in exports 2010-2022
- Premium Statistic Pharmaceutical exports in Mexico 2022, by country
About the region
10
- Premium Statistic Value of drugs and pharma imports from China to India 2019, by segment
- Premium Statistic Annual revenue of Indian pharmaceutical market 2015-2030
- Premium Statistic Indian pharmaceutical export value FY 2012-2024
- Premium Statistic Value of Indian drugs and pharmaceutical exports FY 2017-2019
- Premium Statistic Generic drugs revenue in prescribed drug market in India 2008-2020
- Premium Statistic Distribution of the dietary supplements market in India 2018 by product type
- Premium Statistic Value of the nutraceutical market in India 2012-2022
- Premium Statistic Distribution of the functional food and beverage market in India 2018
- Premium Statistic Distribution of the functional food market in India 2018 by product type
- Premium Statistic Distribution of the functional beverage market in India 2018 by product type
Selected statistics
9
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
Other regions
10
- Premium Statistic Growth rate of generic drugs market volume in Italy 2017-2022, by quarter
- Basic Statistic U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Premium Statistic Subsidized drug expenditure in Australia FY 2016-2022
- Premium Statistic Average CAGR of pharmaceutical spending in Asia 2013-2017, by country
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Pharmaceutical self-care companies in Sweden 2018, by sales value
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Genomma Lab: net income 2013-2021
- Premium Statistic Pharma market value in Colombia 2008-2021
Related statistics
10
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic Lupin's net sales FY 2015-2022
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from ARV formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue share 2023, by market
- Premium Statistic Aurobindo Pharma's revenue from growth market formulations FY 2013-2023
Further related statistics
10
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Construction exports worldwide 2020-2021, by country
- Total value of U.S. clothing imports 2011-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- International tourism receipts of India 2011-2022
- Number of international tourist arrivals in India 2010-2021
- Number of worldwide users of cocaine by region 2010-2021
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Construction exports worldwide 2020-2021, by country
- Total value of U.S. clothing imports 2011-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Walgreens operating income in the U.S. 2005-2023
- Foreign exchange earnings from tourism in India 2000-2022
- International tourism receipts of India 2011-2022
- Number of international tourist arrivals in India 2010-2021
- Number of worldwide users of cocaine by region 2010-2021
CARE Ratings. (December 26, 2018). Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019 [Graph]. In Statista. Retrieved April 29, 2024, from https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/
CARE Ratings. "Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019." Chart. December 26, 2018. Statista. Accessed April 29, 2024. https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/
CARE Ratings. (2018). Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019. Statista. Statista Inc.. Accessed: April 29, 2024. https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/
CARE Ratings. "Net Profit Margin of Indian Pharma Companies from First Half of 2017 to First Half of 2019." Statista, Statista Inc., 26 Dec 2018, https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/
CARE Ratings, Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019 Statista, https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/ (last visited April 29, 2024)
Net profit margin of Indian pharma companies from first half of 2017 to first half of 2019 [Graph], CARE Ratings, December 26, 2018. [Online]. Available: https://www.statista.com/statistics/999327/indian-pharmaceutical-industry-net-profit-margin/